Every major sector has felt the wrath of the novel coronavirus pandemic. However, some industries have completely buckled under pressure — in particular, oil and gas. Oil stocks are a major casualty of the current crisis, and it’s hard to find a name that is not currently flat or down on the year as of
Month: November 2020
In July 2020, McKinsey indicated that 250 vaccine candidates are being pursued globally. The consulting firm also estimated that between five to seven vaccines would be approved in the next two years. Inovio Pharmaceuticals (NASDAQ:INO) has been in the race for the vaccine against Covid-19 and INO stock has exhibited high volatility. Source: Ascannio /
It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. I thought NextEra Energy stock was a buy. Source: madamF / Shutterstock.com And I still do. Here’s why. Renewable Energy Is Not Going Away Before I get
Somehow, it just feels odd to write an analysis of a company with the mighty seafarin’ name of Ocean Power Technologies (NASDAQ:OPTT) when its OPTT stock has a price befitting a kiddie pool: $1.67 per share. This, as you may well know, is penny stock territory and tossing pennies in a fountain (or the “Ocean”
Canopy Growth Corp. (NYSE: CGC; TSX: WEED) is a Canada-based holding company that produces, distributes, and sells a variety of cannabis and hemp-based products for medical and recreational use. Its products include dried flower, hemp, vape pens and cartridges, THC- and CBD-infused beverages, and edibles. Founded in 2013, Canopy Growth faces competition from a large
Some stories — you know, crazy pandemics, crazier elections, craziest wardrobe fails — make so many headlines these days that they’ve shoved otherwise major developments off to the side. One of those, 5G technology, promises to change mobile communications like nothing else in generations. Vying for a nice slice of the pie is Nokia (NYSE:NOK),
When looking at the best entertainment stocks to buy, investors are realizing that upcoming holiday season is unlikely to be the same as the previous years. Another wave of coronavirus infections would imply that consumers are more cautious. However, in the last two months, U.S. consumer confidence has improved and this will translate into higher
When I last wrote about Sorrento Therapeutics (NASDAQ:SRNE) in early October, it was trading around $11.20, well down from its all-time high of $19.39, still up significantly from where it started the year. Source: Shutterstock At the time, I suggested that Sorrento was a better buy in the single digits. Now trading around $6 as
Air travelers walk toward a Lyft pickup area at Los Angeles International Airport (LAX) on August 20, 2020 in Los Angeles, California. Mario Tama | Getty Images The Democrats have gained control of the White House, and Wall Street appears to be on board. Although President-elect Biden will have to grapple with the ongoing coronavirus
The role of a financial advisor is very broad. In general, their job is to guide their clients through the confusing and sometimes overwhelming landscape of investing, tax, estate, and financial management. Ultimately, a financial advisor’s goal is to help each of their clients secure enough money to spend during their lifetime, and, in some
JFrog (FROG) just released its first quarterly earnings report as a publicly traded company. Mid-September, I wondered if this ”liquid software” play was demonstrating on impressive enough performance on the day it went public. Judging by the trading action since the public offering, investors have held good believe in the prospects for the company, yet
It’s been an incredible comeback year for iBio (NYSEAMERICAN:IBIO). Up until 2020, IBIO stock had a long and unfortunate run as a publicly traded investment. Shares dropped from a peak of $55 each in 2011 to as low as 5 cents last year. However, for the fledgling biotech and vaccine company, the novel coronavirus gave it
As a leading developer of renewable energy, NextEra Energy (NASDAQ:NEE) is poised to get a tremendous boost from Joe Biden’s apparent victory in the 2020 presidential election. As a result, I believe that more conservative investors looking for exposure to the solar sector should buy NEE stock. Source: madamF / Shutterstock.com In the 2020 campaign,
In the spring, British multinational oil and gas giant BP PLC (NYSE:BP) was teetering. Walloped by an oil price war, slammed by a precipitous drop in demand thanks to the novel coronavirus pandemic, then caught up in a stock market crash, BP stock fell off a cliff. Source: JuliusKielaitis / Shutterstock.com After a brief post-crash
Check out the companies making headlines before the bell: DR Horton – The homebuilder reported quarterly profit of $2.24 per share, beating the consensus estimate of $1.76, with revenue also above forecasts on an increase in closed sales and net orders. DR Horton also raised its dividend and issued an upbeat 2021 outlook. The shares
Gold vs. Platinum Amex Card: An Overview Let’s face it, there’s a secret pleasure attached to American Express “precious metal” cards, whether Gold or Platinum. Whether it’s from decades of tv brand advertising or simply because you know your boss carries one, you have decided to join the club because membership has its privileges. You
Vehicle rental company Hertz Global (OTCMKTS:HTZGQ) and Hertz stock is no longer traded on the New York Stock Exchange. On Oct. 29, Intercontinental Exchange (NYSE:ICE), which owns the NYSE announced, “the staff of NYSE Regulation has determined to suspend trading in the common stock of Hertz Global Holdings, Inc. (the “Company”) — ticker symbol HTZ —
Digital-medicine company Teladoc Health (NYSE:TDOC) has been one of the most high-profile healthcare companies of 2020. As a result, both buyers and sellers have furiously traded Teladoc stock, pushing the daily volumes to new highs this year. Source: Piotr Swat / Shutterstock.com In late October, Teladoc officially finalized its merger with applied health signals specialist Livongo
Animal lovers, unite! Zomedica Pharmaceuticals (NYSEMKT:ZOM), an under-the-radar play on the pet care space, is having an impressive time in the stock market today. In fact, one big catalyst has ZOM stock up more than 20% today. Source: Shutterstock So what exactly is Zomedica Pharmaceuticals? And what is that big catalyst? Starting with the first
Traders work the floor of the New York Stock Exchange. NYSE Company: F5 Networks, Inc. (FFIV) Business: F5 is a leading provider of multi-cloud application services that allow its customers to develop, deploy, operate, secure and govern applications in any architecture, from on-premises to public cloud. the Company’s Traffic Management Operating System (TMOS) based offerings
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 19
- Next Page »